Cyclophosphamide
Back to searchMolecule Structure
Scientific Name
Cyclophosphamide
Description of the Drug
Cyclophosphamide is a nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00531
http://www.drugbank.ca/drugs/DB00531
Brand Name(s)
Cytoxan
Company Owner(s)
Ingenus Pharmaceuticals Llc, Cipla Ltd, Teva Parenteral Medicines Inc, Eugia Pharma Specialities Ltd, Ani Pharmaceuticals Inc, Sti Pharma Llc, Roxane Laboratories Inc, Amneal Eu Ltd, Jiangsu Hengrui Pharmaceuticals Co Ltd, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
Atlas | cyclophosphamide | ||
SureChEMBL | SCHEMBL4346 | ||
PharmGKB | PA449165 | ||
Human Metabolome Database | HMDB0014672 | ||
DrugBank | DB00531 | ||
PubChem: Thomson Pharma | 14848034 | ||
PubChem | 2907 | ||
Mcule | MCULE-5327530727 | ||
NMRShiftDB | 20208437 | ||
LINCS | LSM-4961 | ||
Nikkaji | J3.385.421H | J2.793F | |
BindingDB | 50237604 | ||
EPA CompTox Dashboard | DTXSID5020364 | ||
DrugCentral | 758 | ||
Brenda | 229311 | 13807 | 229312 |
ChemicalBook | CB8547532 | CB71176228 | |
Guide to Pharmacology | 7154 | ||
rxnorm | CYCLOPHOSPHAMIDE ANHYDROUS | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE LYOPHILIZED |
KEGG Ligand | C07888 | ||
ChEBI | 4027 |